Le Lézard
Classified in: Health
Subjects: PLW, PET, ANW

ISOThrive Awarded Composition of Matter and Production Method Patent for its First "Farmaceuticaltm" to Support Animal Health


HEALDSBURG, Calif., Aug. 31, 2021 /PRNewswire/ -- ISOThrive Inc., a microbiome therapeutics company announced today that the U.S. Patent and Trademark Office has issued a Composition of Matter and Production Method patent for its first Farmaceuticaltm Maltosyl-Isomaltooligosaccharides (MIMOtm), a prebiotic for use as an animal feed additive and pet food supplement. USDA and University of GA studies showed MIMO as highly effective at protecting chickens against antibiotic resistant Salmonella while improving feed efficiency.

ISOThrive opens up a whole new market opportunity to offer higher quality meats that are free of pathogens and also leaner. At the same time, increased food safety is better for workers, less costly for producers and better for the environment. Plus, there are emerging opportunities in pet health with supplements that support better digestion with less reliance on medications.

The widespread use of antibiotics in cattle, swine and chickens can lead to the creation of antibiotic resistant bacterial species.  The same antibiotics used in animal feed are also used to treat disease in humans. With the rise of antibiotic resistant bacteria, eliminating their use in livestock has become a necessity. Prebiotics, while offering a viable alternative to antibiotics, can be expensive to manufacture. This patent covers an economical and efficient method for making (MIMO) that can be used as an additive for animal feed at significantly lower cost. 

"Today's conscious consumer wants a healthier food supply, a better environment for the people that produce the food and has the least amount of environmental impact," said Jack Oswald, ISOThrive's CEO, CTO and Co-Founder. "This new patent allows us to open a new market opportunity while simultaneously positively impacting food safety and security at a cost that makes sense for producers."

Researchers at USDA and University of Georgia found that MIMO added to chicken feed reduced antibiotic resistant Salmonella by 99% while increasing Bifidobacteria.  Feed efficiency was increased by 9-10%.

ABOUT ISOThrive
ISOThrive Inc. is a microbiome therapeutics company focused on human and animal health. pharma.ISOThrive.com

MEDIA CONTACT:   Jack Oswald    [email protected]    855-552-5572

SOURCE ISOThrive Inc.


These press releases may also interest you

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The report titled "Central Lab Market by Service Type (Anatomic Pathology/Histology, Biomarker Services, Genetic Services), Phase (Phase 1, Phase 2, Phase 3), Therapeutic Area, End-use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Personalized Nutrition Market by Measurement Type (Active Measurement, Standard Measurement), Application (Indication-based, Standard Supplements), Distribution Channel, End-Use - Global Forecast 2024-2030" is now available on...

28 mar 2024
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...



News published on and distributed by: